Key result
Baseline mechanical dyssynchrony predicted a higher rate of 6-month clinical improvement after cardiac resynchronization therapy compared to no dyssynchrony.
Why the study?
Does baseline echocardiographic mechanical dyssynchrony predict clinical response to cardiac resynchronization therapy in heart failure patients with QRS <150 ms?
Cohort (n=60)
Does baseline echocardiographic mechanical dyssynchrony predict clinical response to cardiac resynchronization therapy in heart failure patients with QRS <150 ms?
In heart failure patients with a QRS <150 ms, the presence of mechanical dyssynchrony on baseline echocardiography, rather than QRS width, predicts clinical response to cardiac resynchronization therapy.
Answers are grounded in this paper and cite their sources.
Should not yet guide CRT selection in narrow-QRS HF; hypothesis-generating for mechanical dyssynchrony beyond QRS duration.
BACKGROUND: Cardiac resynchronization therapy (CRT) is recommended for patients with NYHA class III-IV refractory heart failure (HF), ejection fraction <35% and a QRS >120 ms. We attempted to identify responders to CRT from echocardiographic (echo) indices of mechanical dyssynchrony in patients with QRS<150 ms. METHODS AND RESULTS: The study enrolled 51 men and 9 women (mean age: 64.5 years) in NYHA class III (n=54) or IV (n=6) presenting with a mean ejection fraction: 25.7%, LV end-diastolic diameter: 69.1 mm, and QRS=121+/-19 ms. All patients were implanted with a CRT system and followed for 1 year. Implantation was preceded and followed by clinical, functional and Doppler (D)-echo evaluation. The primary combined endpoint included 1) death from any cause, 2) HF-related hospitalisations, and 3) NYHA class at 6 months. Before implant, 27 patients had > or =1 echo criterion of mechanical dyssynchrony (DES+ group) and 33 had no evidence of dyssynchrony (DES- group). At 12 months, 8 patients (4 per group) had died, 7 from HF. As regards the primary endpoint at 6 months, 33 patients (55%) had improved, 10 (16%) were unchanged, and 17 (29%) had deteriorated. Clinical improvement was observed in 19 of 27 DES+ (70%), versus 14 of 33 DES- (42%) patients (P<0.04). Baseline QRS duration did not predict response to CRT. CONCLUSIONS: In this population of HF patients with QRS<150 ms, the presence of mechanical dyssynchrony at baseline D-echo examination, but not the QRS width, predicted 6-month clinical response to CRT.
No takes yet. Share an insight, caveat, or question.
Cazeau et al. (2008) conducted a cohort in Heart failure (n=60). Cardiac resynchronization therapy (CRT) with baseline mechanical dyssynchrony (DES+) vs. CRT without baseline mechanical dyssynchrony (DES-) was evaluated on Combined endpoint of death from any cause, HF-related hospitalisations, and NYHA class at 6 months (clinical improvement) (p=<0.04). Baseline mechanical dyssynchrony predicted a higher rate of 6-month clinical improvement after cardiac resynchronization therapy compared to no dyssynchrony.
Synapse has enriched 10 related papers. Consider them for comparative context: